Blood test 'detects breast cancer relapse early'
But charities warn there is a long way to go before the life-saving tests could be made available in hospitals

A simple blood test can accurately detect breast cancer relapses several months before hospital scans, researchers have discovered.
Scientists at London's Institute of Cancer Research have developed a test that can detect small amounts of residual cancer cells that have resisted therapy by looking for tumour DNA in the blood.
The study involved 55 early-stage breast cancer patients who had successfully undergone chemotherapy and surgery.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Their blood was tested at six-month intervals, and doctors were able to "very accurately" predict which patients were likely to suffer a relapse, The Guardian reports.
Patients who tested positive for circulating tumour DNA were 12 times more likely to relapse than those who tested negative and doctors were able to predict the return of the disease nearly eight months before it could be detected by scans.
“Ours is the first study to show that these blood tests could be used to predict relapse," said lead Dr Nicholas Turner, consultant medical oncologist at The Royal Marsden NHS Foundation Trust.
"We also used blood tests to build a picture of how the cancer was evolving over time, and this information could be invaluable to help doctors select the correct drugs to treat the cancer."
Breast cancer is the most prevalent form of the disease among women in Britain, with around 50,000 cases a year. By detecting the cancer earlier, doctors are able to begin treatment sooner and improve a patient's chances of survival.
Scientists say the testing could also potentially be applied to any cancer that has gone through initial treatment and for which there is a risk of relapse in the future.
Turner predicts it will be "some years yet" before the tests could be made available in hospitals, but his team hopes to bring the date closer by carrying out larger clinical trials next year.
However, Nick Peel, from Cancer Research UK, told the BBC that "there is some way to go before this could be developed into a test that doctors could use routinely, and doing so is never simple".
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
5 fundamentally funny cartoons about the US Constitution
Cartoons Artists take on Sharpie edits, wear and tear, and more
-
In search of paradise in Thailand's western isles
The Week Recommends 'Unspoiled spots' remain, providing a fascinating insight into the past
-
The fertility crisis: can Trump make America breed again?
Talking Point The self-styled 'fertilisation president', has been soliciting ideas on how to get Americans to have more babies
-
The Y chromosome degrades over time. And men's health is paying for it
Under the radar The chromosome loss is linked to cancer and Alzheimer's
-
A bacterial toxin could be contributing to the colorectal cancer rise in young people
Under the radar Most exposure occurs in childhood
-
Why are more young people getting bowel cancer?
The Explainer Alarming rise in bowel-cancer diagnoses in under-50s is puzzling scientists
-
Five medical breakthroughs of 2024
The Explainer The year's new discoveries for health conditions that affect millions
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
-
'Beyond belief': fears of asbestos return
Under the radar Attention is returning to the dangers of the carcinogenic substance